IGF1 and neoplasm: Particularly, in addition to the tumor immune escape pathway, genetic markers belonging to the cytokines/interleukins, including CXCL8, CCL5, CCR5 and angiogenic mediators including IGF1, IRF3, NOS2, appear to be the most promising (Figure 3).